@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix this: <http://www.tkuhn.ch/bel2nanopub/RAsdrhSAa3Ca0XiCbDOG23xTuVS_EjQ7dFoBMylwNTBSg> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RAsdrhSAa3Ca0XiCbDOG23xTuVS_EjQ7dFoBMylwNTBSg#> .
@prefix beldoc: <http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix Protein: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080> .
@prefix hgnc: <http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=> .
@prefix geneProductOf: <http://purl.obolibrary.org/obo/RO_0002204> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix orcid: <http://orcid.org/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  sub:_1 geneProductOf: hgnc:10632;
    a Protein: .
  
  sub:_2 geneProductOf: hgnc:4037;
    a Protein: .
  
  sub:_3 occursIn: species:9606;
    rdf:object sub:_2;
    rdf:predicate belv:increases;
    rdf:subject sub:_1;
    a rdf:Statement .
  
  sub:assertion rdfs:label "p(HGNC:CCL5) -> p(HGNC:FYN)" .
}

sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements.";
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved.";
    dce:title "BEL Framework Large Corpus Document";
    pav:authoredBy sub:_5;
    pav:version "1.4" .
  
  sub:_4 prov:value "Treatment of serum starved HeLa-CD4 cells with herbimycin A (the src-kinase inhibitor) and then stimulation with RANTES (10 micro g/ml) for 24 hours inhibited the enhancement of HIV infection caused by RANTES. RANTES induced tyrosine phosphorylation of src kinases. Phosphorylation of Fyn was detected approximately 30 minutes after RANTES addition and increased in intensity for atleast a further 30 minutes. Phosphorylation of Hck was very rapid and the  increase was detectable within 1 min, the response was maximal after 5 minutes, and then the phosphorylation gradually declined. Phosphorylation of c-Src was weakly elevated after 15 minutes and was maximal at 30 minutes. The phosphorylation of cSrc was induced at Tyr-418 residue.";
    prov:wasQuotedFrom pubmed:11836402 .
  
  sub:_5 rdfs:label "Selventa" .
  
  sub:assertion prov:hadPrimarySource pubmed:11836402;
    prov:wasDerivedFrom beldoc:, sub:_4 .
}

sub:pubinfo {
  this: dcterms:created "2014-07-03T14:30:00.945+02:00"^^xsd:dateTime;
    pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}